CoChat

A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway

Open access
Mullenders, Jasper, Fabius, Armida W. M., Madiredjo, Mandy, Bernards, René, Beijersbergen, Roderick L. · 2009 · PLoS ONE
Cited by 144

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The p53 tumor suppressor gene is mutated in about half of human cancers, but the p53 pathway is thought to be functionally inactivated in the vast majority of cancer. Understanding how tumor cells can become insensitive to p53 activation is therefore of major importance. Using an RNAi-based genetic screen, we have identified three novel genes that regulate p53 function. RESULTS: We have screened the NKI shRNA library targeting 8,000 human genes to identify modulators of p53 function. Using the shRNA barcode technique we were able to quickly identify active shRNA vectors from a complex mixture. Validation of the screening results indicates that the shRNA barcode technique can reliable identify active shRNA vectors from a complex pool. Using this approach we have identified three genes, ARNTL, RBCK1 and TNIP1, previously unknown to regulate p53 function. Importantly, ARNTL (BMAL1) is an established component of the circadian regulatory network. The latter finding adds to recent observations that link circadian rhythm to the cell cycle and cancer. We show that cells having suppressed ARNTL are unable to arrest upon p53 activation associated with an inability to activate the p53 target gene p21(CIP1). CONCLUSIONS: We identified three new regulators of the p53 pathway through a functional genetic screen. The identification of the circadian core component ARNTL strengthens the link between circadian rhythm and cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0004798

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 30

  1. KH Vousden, 2007, p53 in health and disease., Nat Rev Mol Cell Biol, 8, 275, 10.1038/nrm2147 · DOI · Paper page
  2. S Chuikov, 2004, Regulation of p53 activity through lysine methylation., Nature, 432, 353, 10.1038/nature03117 · DOI · Paper page
  3. CL Brooks, 2003, Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation., Curr Opin Cell Biol, 15, 164, 10.1016/S0955-0674(03)00003-6 · DOI · Paper page
  4. W Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain., Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
  5. K Berns, 2004, A large-scale RNAi screen in human cells identifies new components of the p53 pathway., Nature, 428, 431, 10.1038/nature02371 · DOI · Paper page
  6. TR Brummelkamp, 2006, An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors., Nat Chem Biol, 2, 202, 10.1038/nchembio774 · DOI · Paper page
  7. R Bernards, 2006, shRNA libraries and their use in cancer genetics., Nat Methods, 3, 701, 10.1038/nmeth921 · DOI
  8. VN Ngo, 2006, A loss-of-function RNA interference screen for molecular targets in cancer., Nature, 441, 106, 10.1038/nature04687 · DOI · Paper page
  9. JM Silva, 2008, Profiling essential genes in human mammary cells by multiplex RNAi screening., Science, 319, 617, 10.1126/science.1149185 · DOI · Paper page
  10. MR Schlabach, 2008, Cancer proliferation gene discovery through functional genomics., Science, 319, 620, 10.1126/science.1149200 · DOI · Paper page
  11. CJ Echeverri, 2006, Minimizing the risk of reporting false positives in large-scale RNAi screens., Nat Methods, 3, 777, 10.1038/nmeth1006-777 · DOI · Paper page
  12. K Heyninck, 1999, The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN., J Cell Biol, 145, 1471, 10.1083/jcb.145.7.1471 · DOI · Paper page
  13. WS el-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression., Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
  14. L Fu, 2002, The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo., Cell, 111, 41, 10.1016/S0092-8674(02)00961-3 · DOI · Paper page
  15. S Panda, 2002, Circadian rhythms from flies to human., Nature, 417, 329, 10.1038/417329a · DOI · Paper page
  16. N Gekakis, 1998, Role of the CLOCK protein in the mammalian circadian mechanism., Science, 280, 1564, 10.1126/science.280.5369.1564 · DOI · Paper page
  17. S Panda, 2002, Coordinated transcription of key pathways in the mouse by the circadian clock., Cell, 109, 307, 10.1016/S0092-8674(02)00722-5 · DOI · Paper page
  18. CJ Sherr, 2006, Divorcing ARF and p53: an unsettled case., Nat Rev Cancer, 6, 663, 10.1038/nrc1954 · DOI · Paper page
  19. X Qian, 2008, Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer., Int J Cancer, 122, 1400, 10.1002/ijc.23243 · DOI
  20. M Ocker, 2007, Histone deacetylase inhibitors: signalling towards p21cip1/waf1., Int J Biochem Cell Biol, 39, 1367, 10.1016/j.biocel.2007.03.001 · DOI · Paper page
  21. G Lagger, 2003, The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene., Mol Cell Biol, 23, 2669, 10.1128/MCB.23.8.2669-2679.2003 · DOI · Paper page
  22. AL Gartel, 2001, Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3., Proc Natl Acad Sci U S A, 98, 4510, 10.1073/pnas.081074898 · DOI · Paper page
  23. K Heyninck, 2003, Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1., FEBS Lett, 536, 135, 10.1016/S0014-5793(03)00041-3 · DOI · Paper page
  24. J Bayle, 2006, The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins., FEBS Lett, 580, 2609, 10.1016/j.febslet.2006.03.093 · DOI
  25. T Kirisako, 2006, A ubiquitin ligase complex assembles linear polyubiquitin chains., Embo J, 25, 4877, 10.1038/sj.emboj.7601360 · DOI · Paper page
  26. Y Tian, 2007, RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation., J Biol Chem, 282, 16776, 10.1074/jbc.M701913200 · DOI · Paper page
  27. K Tatematsu, 2005, Nuclear-cytoplasmic shuttling of a RING-IBR protein RBCK1 and its functional interaction with nuclear body proteins., J Biol Chem, 280, 22937, 10.1074/jbc.M413476200 · DOI
  28. T Matsuo, 2003, Control mechanism of the circadian clock for timing of cell division in vivo., Science, 302, 255, 10.1126/science.1086271 · DOI · Paper page
  29. MW Young, 2001, Time zones: a comparative genetics of circadian clocks., Nat Rev Genet, 2, 702, 10.1038/35088576 · DOI · Paper page
  30. A Grechez-Cassiau, 2008, The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation., J Biol Chem, 283, 4535, 10.1074/jbc.M705576200 · DOI · Paper page

Cited by

See all 144

Metadata

Authors
Mullenders, J., Fabius, A. W. M., Madiredjo, M., Bernards, R., & Beijersbergen, R. L.
Venue
PLoS ONE
Published
2009-03-11
Volume
4
Issue
3
Pages
e4798
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2016397316
Cited by
144
References
17
FWCI
5.52
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.